CAPE CANAVERAL, Fla.–(BUSINESS WIRE)–Maxxsure, LLC, an independent cyber risk assessment, scoring and
insurance company providing a quantitative framework-based solution that
builds detailed assessments and quantification of processes,
hardware/software and network vulnerabilities, has entered into a
strategic partnership with SAFE-BioPharma Association, LLC, which
manages the global SAFE-BioPharma® digital identity and
signature standards.
Maxxsure plans to incorporate the SAFE-BioPharma requirements into its
M-Score™ cyber risk assessment and scoring platform, allowing member
companies to continuously evaluate their compliance relative to the
SAFE-BioPharma identity trust standards. Organizations deploying
M-Score™ will receive a quantified score that rates their overall cyber
risk, including the effectiveness of the company’s cyber management,
cyber risk exposure and supply chain management.
“Compliance and risk management are very high priorities for companies
in the healthcare and biopharmaceutical industries. With continued use
…
